| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 05/09/2001 | EP1097147A1 Novel angiogenesis inhibitors |
| 05/09/2001 | EP1097142A1 Phthalazine derivatives phosphodiesterase 4 inhibitors |
| 05/09/2001 | EP1097137A1 N-substituted naphthalene carboxamides as neurokinin-receptor antagonists |
| 05/09/2001 | EP1096925A2 Use of inhibitors of prenyltransferases for for inhibiting fungal growth |
| 05/09/2001 | CN1294580A Indole derivatives with antiviral activity |
| 05/09/2001 | CN1065532C Thiazolidine and oxaxoliding derivatives, their prepn. and their medical use |
| 05/08/2001 | US6228942 Dehydration to esterify or amidate surface of oxidized or aminated carbon powder or fiber suspended in solution containing a monomer or polymer having amine, hydroxy, and/or viny ether groups |
| 05/08/2001 | US6228808 Carbamoylphenylsulfonylureas, processes for their preparation and their use as herbicides and plant growth regulators |
| 05/08/2001 | CA2032330C Benzyl-substituted rhodanine derivatives for treating inflammatory bowel disease |
| 05/03/2001 | WO2001030778A1 Thiazole and imidazo [4,5-b] pyridine compounds and their pharmaceutical use |
| 05/03/2001 | WO2001030766A1 Phthalazinone derivatives as pde 4 inhibitors |
| 05/03/2001 | WO2001030762A1 Imidazol-4-ylmethanols use as inhibitors of steroid c17-20 lyase |
| 05/03/2001 | WO2001030749A1 Novel compounds |
| 05/03/2001 | WO2001030387A1 Preventives or remedies for arrhythmia |
| 05/03/2001 | WO2001007439A3 Process for the production of epothiolone b and derivatives as well as intermediate products for this process |
| 05/03/2001 | CA2388479A1 Preventives or remedies for arrhythmia |
| 05/03/2001 | CA2388121A1 Phthalazinone derivatives as pde 4 inhibitors |
| 05/03/2001 | CA2387869A1 Imidazol-4-ylmethanols use as inhibitors of steroid c17-20 lyase |
| 05/02/2001 | EP1095936A1 Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses, and methods and intermediates useful for their preparation |
| 05/02/2001 | EP1095935A1 6-Hydroxy-5,6-dihydrouracils as herbicides |
| 05/02/2001 | EP1094826A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors |
| 05/02/2001 | EP1094816A1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 05/02/2001 | EP1078926A9 Pyran derivatives |
| 05/02/2001 | EP0984959A4 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds |
| 05/02/2001 | EP0983257A4 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds |
| 05/02/2001 | EP0973392A4 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 05/02/2001 | EP0885218B1 Oxa- and thia-diazole muscarinic receptor antagonists |
| 05/02/2001 | EP0769947B1 Indolinone compounds for the treatment of disease |
| 05/02/2001 | CN1293673A 1-(3-heteroarylpropyl-or-prop-2-enyl)-4-benzylpiperidines used as NMDA receptor antagonists |
| 05/02/2001 | CN1293669A Benzylpiperazingl-and benzylipeeridinyl ethanone derivatives, their preparation method and their use as dopamine D receptor antagonists |
| 05/02/2001 | CN1293665A New compounds and their use as positive AMPA receptor modulators |
| 05/02/2001 | CN1065242C Byridyl-thiazoles |
| 05/01/2001 | US6225478 Iridoid derivatives and neovascularization inhibitors containing the same as active ingredient |
| 05/01/2001 | US6225335 3-(4′-bromobenzylindenyl)-2-indolinone and analogues thereof for the treatment of disease |
| 05/01/2001 | US6225330 For treatment of abnormal conditions such as feeding disorders (obesity and bulimia nervosa), sexual/reproductive disorders, depression, epileptic seizure, hypertension, cerebral hemorrhage, congestive heart failure, sleep disturbances |
| 05/01/2001 | US6225324 Antidepressant heterocyclic compounds |
| 04/26/2001 | WO2001029029A1 Tetrahydrobenzindolone derivatives, their preparation and their use as 5-ht7 receptor antagonists |
| 04/26/2001 | WO2001029028A1 9- (piperazinylalkyl) carbazoles as bax-modulators |
| 04/26/2001 | WO2001029025A2 Tyrosine kinase inhibitors |
| 04/26/2001 | WO2001029021A1 Neuraminidase inhibitors |
| 04/26/2001 | WO2001029012A2 Benzodiazepine derivatives as metabotropic glutamate receptor antagonists |
| 04/26/2001 | WO2001029011A2 Benzodiazepine derivatives as metabotropic glutamate receptor antagonists |
| 04/26/2001 | WO2001028996A2 Pyrrolidine derivatives, their preparation and their use as inhibitors of neuraminidases |
| 04/26/2001 | WO2001028987A1 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
| 04/26/2001 | WO2001028561A1 Gram-positive selective antibacterial compounds, compositions containing such compounds and methods of treatment |
| 04/26/2001 | WO2001028537A2 Bissulfonamide derivatives as enzyme inhibitors |
| 04/26/2001 | WO2000059902A3 Aryl sulfonyls as factor xa inhibitors |
| 04/26/2001 | WO2000055125A3 N-cyanomethyl amides as protease inhibitors |
| 04/26/2001 | DE19932621A1 Neue substituerte alpha, beta-anellierte Butyrolactone New substituerte alpha, beta-fused butyrolactones |
| 04/26/2001 | CA2388859A1 Inhibitors of neuraminidases |
| 04/26/2001 | CA2387593A1 Enzyme inhibitors |
| 04/26/2001 | CA2384240A1 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
| 04/25/2001 | EP1094063A1 9-(Piperazinylalkyl)carbazoles as Bax-modulators |
| 04/25/2001 | EP1093372A1 CYCLIC AMINO ACID COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING $g(b)-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS |
| 04/25/2001 | EP1093367A1 Protease inhibitors |
| 04/25/2001 | CN1292788A Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 04/25/2001 | CN1064962C Arylalkyl-thiadiazinones |
| 04/24/2001 | US6222048 Diaryl-2-(5H)-furanones as Cox-2 inhibitors |
| 04/24/2001 | US6222040 Selective NPY (Y5) antagonists (tricyclics) |
| 04/24/2001 | US6221865 Inhibitors of protein farnesyltransferase and protein geranylgeranyltransferase. |
| 04/24/2001 | US6221574 Spectral sensitizers |
| 04/24/2001 | CA2166203C Processes and intermediates for the preparation of 5-[2-(4-(benzoisothiazol-3-yl)-piperazin-1-yl)ethyl]- 6-chloro-1,3-dihydro-indol-2-one |
| 04/19/2001 | WO2001027308A2 13-alkyl epothilone derivatives |
| 04/19/2001 | WO2001027145A1 Antibody catalysis of enantio- and diastereo-selective aldol reactions |
| 04/19/2001 | WO2001027128A1 C-aryl glucoside sglt2 inhibitors |
| 04/19/2001 | WO2001027108A1 AMINO LACTAM SULFONAMIDES AS INHIBITORS OF Aβ PROTEIN PRODUCTION |
| 04/19/2001 | WO2001027107A2 Heterocyclic sodium/proton exchange inhibitors and method |
| 04/19/2001 | WO2001027096A1 Aminomethyl-(hetero)aryl derivatives and their use as tryptase inhibitors |
| 04/19/2001 | WO2001027094A1 Hypertriglyceridemia remedies and antiobestics |
| 04/19/2001 | WO2001027091A1 AMINO LACTAM SULFONAMIDES AS INHIBITORS OF Aβ PROTEIN PRODUCTION |
| 04/19/2001 | WO2001027089A1 Pyrimidine derivatives |
| 04/19/2001 | WO2001027080A2 5-substituted indolinones and use thereof as kinase and cyclin/cdk complex inhibitors |
| 04/19/2001 | WO2001026656A2 5-membered heterocycle derivatives and use thereof as monoamine oxidase inhibitors |
| 04/19/2001 | WO2001002558A8 Probe for analysis of nucleic acids |
| 04/19/2001 | WO2000018767A9 2-piperazino alkylamino benzoazole derivatives: dopamine receptor subtype specific ligands |
| 04/19/2001 | US20010000344 N-(2-(R)-amino-3-mercaptopropyl)-L-penicillaminyl-1,2,3,4 -tetrahydro-3(S)-isoquinoline carbonyl methionine methylester cyclic disulfide, for example; administering as antitumor agent or to treat restenosis |
| 04/19/2001 | DE19949209A1 In 5-Stellung substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel In the 5-position substituted indolinones, their preparation and their use as medicaments |
| 04/19/2001 | CA2425620A1 13-alkyl epothilone derivatives |
| 04/19/2001 | CA2388813A1 Heterocyclic sodium/proton exchange inhibitors and method |
| 04/19/2001 | CA2388505A1 5-membered heterocycle derivatives, their preparation and application as medicine |
| 04/19/2001 | CA2387493A1 Amino lactam sulfonamides as inhibitors of a.beta. protein production |
| 04/19/2001 | CA2384544A1 Amino lactam sulfonamides as inhibitors of a.beta. protein production |
| 04/19/2001 | CA2382605A1 Pyrimidine derivatives |
| 04/18/2001 | EP1092715A2 Cyano-indole derivatives as inhibitors of serotonin reuptake, method for their preparation and pharmaceutical compositions containing the same |
| 04/18/2001 | EP1092711A1 Retinoid-associated receptor regulators |
| 04/18/2001 | EP1091955A1 Quinolones as serine protease inhibitors |
| 04/18/2001 | EP1091943A1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 04/18/2001 | EP1091942A1 Potassium channel blocking agents |
| 04/18/2001 | EP0682663B1 4-hydroxy-benzopyran-2-ones and 4-hydroxy-cycloalkyl b]pyran-2-ones useful to treat retroviral infections |
| 04/18/2001 | CN1291993A Thiadiazole compounds useful as inhibitors of cysteine activity dependent enzymes |
| 04/18/2001 | CN1291984A Glycine transport inhibitors |
| 04/18/2001 | CN1291892A Substituted oxoazaheterocyclyl factor Xa inhibitors |
| 04/18/2001 | CN1064682C Pyrrolidine derivatives having phospholipase A2 inhibitor activity |
| 04/18/2001 | CN1064681C Heterocyclic compounds |
| 04/18/2001 | CN1064679C Herbicidal thiocarbamoyltetrazolinones |
| 04/17/2001 | US6218544 Heterocyclic esters and amides |
| 04/17/2001 | US6218431 Substituted biphenyls |
| 04/17/2001 | US6218423 Administering pyrrolidine derivative for therapy of nerve-related vision disorder, improving vision, treating memory impairment, or enhancing memory performance in animal |
| 04/17/2001 | US6218418 Therapy of cell proliferative disorders associated with an altered cell dependent kinase activity by administering amino pyrazole derivative to mammal |
| 04/17/2001 | US6218413 Oxazolidinone antibacterial agents having a thiocarbonyl functionality |